Stock Track | HANSOH PHARMA Soars 7.32% in Intraday Trading Following Strong Annual Results

Stock Track03-31

HANSOH PHARMA's stock price surged 7.32% during Tuesday's intraday trading session, reflecting strong investor response to the company's latest financial performance.

The significant price movement follows the company's announcement of its 2025 annual results, which showed robust growth across key financial metrics. The pharmaceutical group reported revenue of RMB 150.28 billion, representing a 22.57% year-on-year increase, while profit attributable to owners reached RMB 55.55 billion, marking an impressive 27.07% growth compared to the previous year.

Notably, revenue from innovative drugs and partnered products reached approximately RMB 123.54 billion, accounting for about 82.2% of total revenue and establishing this segment as the core driver for the group's sustainable performance growth. The company has also proposed a final dividend of HK 20.0 cents per share.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1150411616?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-31 10:52","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1150411616","market":"sg","top_or_hot":-1,"title":"Stock Track | HANSOH PHARMA Soars 7.32% in Intraday Trading Following Strong Annual Results","media":"Stock Track","content":"<p>HANSOH PHARMA's stock price surged 7.32% during Tuesday's intraday trading session, reflecting strong investor response to the company's latest financial performance.</p><p>The significant price movement follows the company's announcement of its 2025 annual results, which showed robust growth across key financial metrics. The pharmaceutical group reported revenue of RMB 150.28 billion, representing a 22.57% year-on-year increase, while profit attributable to owners reached RMB 55.55 billion, marking an impressive 27.07% growth compared to the previous year.</p><p>Notably, revenue from innovative drugs and partnered products reached approximately RMB 123.54 billion, accounting for about 82.2% of total revenue and establishing this segment as the core driver for the group's sustainable performance growth. The company has also proposed a final dividend of HK 20.0 cents per share.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | HANSOH PHARMA Soars 7.32% in Intraday Trading Following Strong Annual Results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | HANSOH PHARMA Soars 7.32% in Intraday Trading Following Strong Annual Results\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-03-31 10:52</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>HANSOH PHARMA's stock price surged 7.32% during Tuesday's intraday trading session, reflecting strong investor response to the company's latest financial performance.</p><p>The significant price movement follows the company's announcement of its 2025 annual results, which showed robust growth across key financial metrics. The pharmaceutical group reported revenue of RMB 150.28 billion, representing a 22.57% year-on-year increase, while profit attributable to owners reached RMB 55.55 billion, marking an impressive 27.07% growth compared to the previous year.</p><p>Notably, revenue from innovative drugs and partnered products reached approximately RMB 123.54 billion, accounting for about 82.2% of total revenue and establishing this segment as the core driver for the group's sustainable performance growth. The company has also proposed a final dividend of HK 20.0 cents per share.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03692","symbol_name":"翰森制药","start_time":0,"source_url":"","article_id":"1150411616","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1150411616","pubTimestamp":1774925564,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"HANSOH PHARMA's stock price surged 7.32% during Tuesday's intraday trading session, reflecting strong investor response to the company's latest financial performance.The significant price movement...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03692":"翰森制药"},"translate_title":"个股追踪|豪森药业强劲年报业绩盘中大涨7.32%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03692":1},"content_text":"HANSOH PHARMA's stock price surged 7.32% during Tuesday's intraday trading session, reflecting strong investor response to the company's latest financial performance.The significant price movement follows the company's announcement of its 2025 annual results, which showed robust growth across key financial metrics. The pharmaceutical group reported revenue of RMB 150.28 billion, representing a 22.57% year-on-year increase, while profit attributable to owners reached RMB 55.55 billion, marking an impressive 27.07% growth compared to the previous year.Notably, revenue from innovative drugs and partnered products reached approximately RMB 123.54 billion, accounting for about 82.2% of total revenue and establishing this segment as the core driver for the group's sustainable performance growth. The company has also proposed a final dividend of HK 20.0 cents per share.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1150411616","isCrawlerRequest":true}